•
Mar 31, 2022

DaVita Q1 2022 Earnings Report

DaVita's financial performance was impacted by COVID-19 volume pressures and higher wage rate increases.

Key Takeaways

DaVita Inc. reported consolidated revenues of $2.818 billion and operating income of $338 million for the quarter ended March 31, 2022. Diluted earnings per share was $1.61. The company repurchased 2.1 million shares of its common stock at an average cost of $110.90 per share.

Consolidated revenues were $2.818 billion.

Operating income was $338 million.

Diluted earnings per share was $1.61.

Operating cash flow and free cash flow were $322 million and $147 million, respectively.

Total Revenue
$2.82B
Previous year: $2.82B
-0.1%
EPS
$1.61
Previous year: $2.09
-23.0%
US Dialysis Treatments
7.11M
Previous year: 7.29M
-2.4%
US Avg Treatments per day
92.34K
Previous year: 94.64K
-2.4%
US Revenue per Treatment
$361
Previous year: $355
+1.9%
Gross Profit
$799M
Previous year: $882M
-9.4%
Cash and Equivalents
$328M
Previous year: $884M
-63.0%
Free Cash Flow
$147M
Previous year: -$17M
-964.7%
Total Assets
$17.1B
Previous year: $17.6B
-3.2%

DaVita

DaVita

DaVita Revenue by Segment

DaVita Revenue by Geographic Location

Forward Guidance

DaVita provided its 2022 guidance for adjusted operating income, adjusted diluted net income per share attributable to DaVita Inc., and free cash flow.

Positive Outlook

  • Adjusted operating income between $1.525 billion and $1.675 billion.
  • Adjusted diluted net income per share attributable to DaVita Inc. between $7.50 and $8.50.
  • Free cash flow between $850 million and $1.100 billion.

Challenges Ahead

  • Guidance excludes foreign currency fluctuations, which may be significant.
  • Guidance for effective income tax rate on adjusted income attributable to DaVita Inc. excludes the amount of third-party owners' income and related taxes attributable to non-tax paying entities.

Revenue & Expenses

Visualization of income flow from segment revenue to net income